Pharmacists can work alongside dermatologists, nurses, and other health care professionals to help answer skin care–related questions and help patients understand trial outcomes.
|Articles|August 23, 2022
Daily OTC Pearl: Triple Paste Ointment
Author(s)Saro Arakelians, PharmD
Triple Paste Ointment is used to treat rashes, including diaper rash.
Advertisement
OTC/Lifestyle Pearl of the Day: Triple Paste Ointment
Indication: Triple Paste Ointment is used to treat rashes, including diaper rash.
Insight:
- This medicated ointment helps to soothe, treat, and prevent red, irritated skin caused by diaper rash.
- Formulated with zinc oxide to seal out moisture, protect skin, and promote healing.
- Active ingredient: zinc oxide 12.8% (skin protectant). Inactive ingredients: white petrolatum, corn starch, anhydrous lanolin, stearyl alcohol, beeswax, bisabolol, cholesterol, water, glycerin, oat (avena sativa) kernel extract, polysorbate 80.
- Apply ointment liberally as often as necessary, with each diaper change, especially at bedtime or any time when exposure to wet diapers may be prolonged.
Advertisement
Related to this article
From survodutide titration to oral PCSK9 adherence and HF care models, AHA 2026 experts pointed to pharmacists as key to putting new data into practice.
Christie Ballantyne, MD, says high extension enrollment and a single 20-mg daily dose are encouraging signs for patient adherence to oral enlicitide.
An ASRA-recognized quality improvement project draws attention to injectate reproducibility, offering a starting point for examining medication preparation and pharmacists’ role in safer pain procedures.
A meta-analysis presented at IDWeek 2026 found responses were stronger after chemotherapy but waned within a year, supporting a 2-dose strategy.
How should a factor XIa inhibitor be incorporated into secondary stroke prevention?
Inconsistent state immunization laws complicate pharmacy operations and limit patient access.
Pharmacists can strengthen opioid safety through individualized counseling, overdose prevention, and coordinated follow-up that keeps patients involved in treatment decisions.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Glucose Monitoring: Timing Makes Every Reading Count
2
FDA Reportedly Shelves Commissioner's National Priority Voucher Program
3
Belantamab Mafodotin Moves Into Lenalidomide-Refractory Myeloma in Updated NCCN Guidelines
4
AHA 2026: Pharmacists at the Center of Cardiometabolic Care
5